Skip to main content
. 2021 Jul 23;11:629633. doi: 10.3389/fonc.2021.629633

Figure 4.

Figure 4

The expression level of GMFG in breast cancer and its correlation with survival in breast cancer. (A) The differential expression of GMFG in multiple tumor types were analyzed by TIMER online platform (*p < 0.05, **p < 0.01, ***p < 0.001). (B) Differentiated expression of GMFG in the normal breast tissues and breast cancer tissues, which was assessed by the Wilcoxon test (***p < 0.001). (C) Paired differentiation analysis was used to analyze GMFG expression in tumor-adjacent normal tissues and tumor tissues from the same patient, which was also assessed by the Wilcoxon test (***p < 0.001). (D) Prognostic significances of GMFG expression in breast cancer patients based on the Kaplan-Meier Plotter database. (E) Prognostic significances of GMFG expression in breast cancer patients based on the METABRIC database.